Paper41359142
Nanotechnology in COVID-19 prevention, diagnosis, and treatment: a comprehensive review.
Dikamu M and 5 others. Discov Nano, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Nanotechnology in COVID-19 prevention, diagnosis, and treatment: a comprehensive review. Papers, record 41359142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41359142
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References191
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32727050 | 3D Printing to Support the Shortage in Personal Protective Equipment Caused by COVID-19 Pandemic. | Materials (Basel) | 2020 | https://conductscience.org/library/papers/32727050 | PubMed |
| 2 | 33613145 | Current understanding of the surface contamination and contact transmission of SARS-CoV-2 in healthcare settings. | Environ Chem Lett | 2021 | https://conductscience.org/library/papers/33613145 | PubMed |
| 3 | 38116958 | Virus-like particles as powerful vaccination strategy against human viruses. | Rev Med Virol | 2024 | https://conductscience.org/library/papers/38116958 | PubMed |
| 4 | 33932543 | Nanotechnology-based approaches for emerging and re-emerging viruses: Special emphasis on COVID-19. | Microb Pathog | 2021 | https://conductscience.org/library/papers/33932543 | PubMed |
| 5 | 36423041 | Nanoparticle-Based Delivery Systems for Vaccines. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/36423041 | PubMed |
| 6 | 36711425 | Tackling COVID-19 Using Antiviral Nanocoating's-Recent Progress and Future Challenges. | Part Part Syst Charact | 2023 | https://conductscience.org/library/papers/36711425 | PubMed |
| 7 | 37323463 | Nano-biosensor for SARS-CoV-2/COVID-19 detection: methods, mechanism and interface design. | RSC Adv | 2023 | https://conductscience.org/library/papers/37323463 | PubMed |
| 8 | 36723177 | Adsorption and Inactivation of SARS-CoV-2 on the Surface of Anatase TiO2(101). | ACS Appl Mater Interfaces | 2023 | https://conductscience.org/library/papers/36723177 | PubMed |
| 9 | 26454828 | Multiplexed detection of influenza A virus subtype H5 and H9 via quantum dot-based immunoassay. | Biosens Bioelectron | 2016 | https://conductscience.org/library/papers/26454828 | PubMed |
| 10 | 32657566 | A Surface Coating that Rapidly Inactivates SARS-CoV-2. | ACS Appl Mater Interfaces | 2020 | https://conductscience.org/library/papers/32657566 | PubMed |
| 11 | 29770813 | Nanomaterial-based devices for point-of-care diagnostic applications. | Chem Soc Rev | 2018 | https://conductscience.org/library/papers/29770813 | PubMed |
| 12 | 29768232 | Enhanced wound healing activity of Ag-ZnO composite NPs in Wistar Albino rats. | IET Nanobiotechnol | 2018 | https://conductscience.org/library/papers/29768232 | PubMed |
| 13 | 39820009 | Cobalt oxide nanoparticles induce cytotoxicity and excessive ROS mediated mitochondrial dysfunction and p53-independent apoptosis in melanoma cells. | Sci Rep | 2025 | https://conductscience.org/library/papers/39820009 | PubMed |
| 14 | 29324805 | Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses. | PLoS One | 2018 | https://conductscience.org/library/papers/29324805 | PubMed |
| 15 | 32336860 | Quantitative and sensitive detection of SARS coronavirus nucleocapsid protein using quantum dots-conjugated RNA aptamer on chip. | J Chem Technol Biotechnol | 2011 | https://conductscience.org/library/papers/32336860 | PubMed |
| 16 | 34761549 | A Multifunctional Neutralizing Antibody-Conjugated Nanoparticle Inhibits and Inactivates SARS-CoV-2. | Adv Sci (Weinh) | 2022 | https://conductscience.org/library/papers/34761549 | PubMed |
| 17 | 32410309 | In Situ Formation of Polymeric Nanoassemblies Using an Efficient Reversible Click Reaction. | Angew Chem Int Ed Engl | 2020 | https://conductscience.org/library/papers/32410309 | PubMed |
| 18 | 37117161 | Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37117161 | PubMed |
| 19 | 36322769 | Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/36322769 | PubMed |
| 20 | 37682455 | Nanotechnology-based theranostic and prophylactic approaches against SARS-CoV-2. | Immunol Res | 2024 | https://conductscience.org/library/papers/37682455 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42070214 | Bio-assisted synthesis, characterization, and antibacterial efficacy of titanium dioxide nanoparticles mediated by Pterolobium hexapetalum leaf extract. | Discov Nano | 2026 | https://conductscience.org/library/papers/42070214 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41359142
GET https://conductscience.org/api/papers/v1/41359142/references?page=2